Jun Deng

1.5k total citations
35 papers, 997 citations indexed

About

Jun Deng is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Deng has authored 35 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Deng's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Blood properties and coagulation (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Jun Deng is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Blood properties and coagulation (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Jun Deng collaborates with scholars based in China and United States. Jun Deng's co-authors include Yu Hu, Heng Mei, Yadan Wang, Min Xu, Danying Liao, Yong Gao, Lu Tang, Liqiong Cai, Zhihui Wang and Hongbo Wang and has published in prestigious journals such as Blood, PLoS ONE and Biomaterials.

In The Last Decade

Jun Deng

33 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Deng China 14 388 285 208 141 141 35 997
Tao Yan China 18 491 1.3× 128 0.4× 145 0.7× 29 0.2× 192 1.4× 87 1.1k
Yi-Zhou Jiang China 20 1.1k 2.9× 173 0.6× 499 2.4× 48 0.3× 139 1.0× 35 1.5k
Huiyan Sun China 24 1.4k 3.6× 67 0.2× 913 4.4× 41 0.3× 260 1.8× 81 2.1k
Simona De Summa Italy 23 917 2.4× 100 0.4× 537 2.6× 47 0.3× 491 3.5× 88 1.7k
Roza Motavalli Iran 15 374 1.0× 63 0.2× 76 0.4× 44 0.3× 539 3.8× 44 1.2k
Yoonjung Kim South Korea 20 342 0.9× 54 0.2× 199 1.0× 57 0.4× 220 1.6× 95 1.2k
Yicheng Zhang China 18 330 0.9× 64 0.2× 51 0.2× 41 0.3× 414 2.9× 126 1.1k
Ingrid Boehm Australia 13 358 0.9× 91 0.3× 83 0.4× 79 0.6× 167 1.2× 20 865
Evangelos Tsiambas Greece 16 445 1.1× 96 0.3× 191 0.9× 26 0.2× 311 2.2× 103 977
Thomas Bukur Germany 12 646 1.7× 103 0.4× 120 0.6× 17 0.1× 445 3.2× 21 1.4k

Countries citing papers authored by Jun Deng

Since Specialization
Citations

This map shows the geographic impact of Jun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Deng more than expected).

Fields of papers citing papers by Jun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Deng. The network helps show where Jun Deng may publish in the future.

Co-authorship network of co-authors of Jun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Deng. A scholar is included among the top collaborators of Jun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Deng. Jun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Jun, et al.. (2025). Innovative rapid screening for complex BCR-ABL1 kinase domain mutations in TKI-treated leukaemia patients. British Journal of Cancer. 133(5). 674–684.
2.
Zhang, Jun, et al.. (2025). Ultrasound-triggered drug-loaded nanobubbles for enhanced T cell recruitment in cancer chemoimmunotherapy. Biomaterials. 317. 123086–123086. 6 indexed citations
3.
Li, Zixuan, Jun Deng, Ping Yin, et al.. (2024). New ABL1 Kinase Domain Mutations in BCR::ABL1‐Positive Acute Lymphoblastic Leukemia. Cancer Medicine. 13(20). e70317–e70317. 1 indexed citations
4.
Wu, Huimin, Hao Ji, Yi Luo, et al.. (2024). Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey. Virology Journal. 21(1). 299–299. 1 indexed citations
5.
Wang, Hongfei, Huafang Wang, Jun Deng, et al.. (2023). Season of delivery and risk of venous thromboembolism during hospitalization among pregnant women. Frontiers in Public Health. 11. 1272149–1272149.
6.
Li, Yijin, et al.. (2023). Double-edged functions of hemopexin in hematological related diseases: from basic mechanisms to clinical application. Frontiers in Immunology. 14. 1274333–1274333. 2 indexed citations
7.
Xu, Aoshuang, Jiasi Zhang, Liping Zuo, et al.. (2021). FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner. Molecular Therapy. 30(3). 1104–1118. 50 indexed citations
8.
Chen, Shuai, Anish V. Sharda, Jun Deng, et al.. (2021). Anti-thrombotic effects mediated by dihydromyricetin involve both platelet inhibition and endothelial protection. Pharmacological Research. 167. 105540–105540. 30 indexed citations
9.
Liao, Danying, Fen Zhou, Lili Luo, et al.. (2020). Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology. 7(9). e671–e678. 328 indexed citations
12.
Deng, Jun, Heng Mei, Wei Shi, et al.. (2018). Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion. Current Medical Science. 38(3). 427–435. 19 indexed citations
13.
Wang, Yadan, Xiaofei Wu, Jun Deng, et al.. (2016). Diagnostic application of next-generation sequencing inZMYM2-FGFR18p11 myeloproliferative syndrome: A case report. Cancer Biology & Therapy. 17(8). 785–789. 6 indexed citations
14.
Zhang, Bo, Ting Jiang, Xiaojian She, et al.. (2016). Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice. Biomaterials. 96. 63–71. 38 indexed citations
16.
Han, Yan, Qiuling Wu, Chenyu Sun, et al.. (2014). piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma. Leukemia. 29(1). 196–206. 195 indexed citations
17.
Shi, Wei, Heng Mei, Jun Deng, et al.. (2013). The delivery of thrombi-specific nanoparticles incorporating oligonucleotides into injured cerebrovascular endothelium. Biomaterials. 34(16). 4128–4136. 10 indexed citations
18.
Chen, Chen, Heng Mei, Wei Shi, et al.. (2013). EGFP-EGF1-Conjugated PLGA Nanoparticles for Targeted Delivery of siRNA into Injured Brain Microvascular Endothelial Cells for Efficient RNA Interference. PLoS ONE. 8(4). e60860–e60860. 30 indexed citations
19.
Shi, Wei, Heng Mei, Jun Deng, et al.. (2012). A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Biomaterials. 33(30). 7643–7654. 29 indexed citations
20.
Mei, Heng, Wei Shi, Zhiqing Pang, et al.. (2010). EGFP-EGF1 protein-conjugated PEG–PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials. 31(21). 5619–5626. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026